Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy

61Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Objectives - Proton magnetic resonance spectroscopy (1H-MRS) localised to the lentiform nucleus, was carried out in eight patients with idiopathic Parkinson's disease and five patients with progressive supranuclear palsy. The aim of the study was to assess the concentration of N-acetyl-aspartate (NAA), creatine and phosphocreatine (Cr), and choline containing compounds (Cho) in the putamen and globus pallidus of these patients. Methods - Peak ratios obtained from patients were compared with those from nine healthy age matched controls. Results - NAA/Cho and NAA/Cr ratios were reduced significantly in patients with progressive supranuclear palsy. Conclusion - These results suggest an NAA deficit, due to neuronal loss, in the lentiform nucleus of these patients. 1H-MRS is a non-invasive technique that can provide useful information concerning striatal neuronal loss in the basal ganglia of patients with parkinsonian syndromes.

Cite

CITATION STYLE

APA

Federico, F., Simone, I. L., Lucivero, V., De Mari, M., Giannini, P., Iliceto, G., … Lamberti, P. (1997). Proton magnetic resonance spectroscopy in Parkinson’s disease and progressive supranuclear palsy. Journal of Neurology Neurosurgery and Psychiatry, 62(3), 239–242. https://doi.org/10.1136/jnnp.62.3.239

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free